The first antibacterial glass production line in C

  • Detail

The first antibacterial glass production line in China has been put into operation, breaking the international monopoly

frequently touching 6 every day. The right angle difference between the steel bar and the steel plate is no more than 4 degrees. Many bacteria will be left on the screen. Some institutions have detected that it is 10 times dirtier than the express package. If the glass film has antibacterial function, it will bring a "double guarantee" to reduce wear and bacterial invasion. At the beginning of this month, Kelisi Material Technology Co., Ltd., located in Fuzhou Development Zone, broke the international monopoly and officially produced the first antibacterial glass production line. Kelisi became the second enterprise in the world and the first enterprise in China with antibacterial glass production technology

2013, Corning demonstrated the working principle of the reducer of the spring tension testing machine: the world's first antibacterial glass technology, monopolizing the global market at one fell swoop. Now, this technical barrier has been broken by kelishi. "Our products use the same principle as Corning, but the technology is different." Huang Tuozhong, the special assistant of president of Kelisi, said that through the special silver ion implantation technology, Kelisi's glass products can inhibit the breeding of algae, micro bacteria, molds, fungi and other harmful bacteria. "What's more, because the silver ions are deeply embedded in the glass and integrated with the glass, the antibacterial performance is the inherent characteristic of the glass, which can permanently inhibit bacteria."

last year, Keli applied for a patent as an antibacterial glass product. After mass production, consumers will soon be able to buy the antibacterial film produced by the company in China

Huang Tuozhong told us that not only the antibacterial performance is comparable to that of Corning's products, but also the light transmission performance has been optimized. Corning's current antibacterial glass film will make the screen color yellow. Kelistv has developed a new technology to implant silver ions and other metal ions to solve the problem of yellow

it is understood that all R & D, including antibacterial, translucent and hardness properties, comes from the cross-strait advanced material R & D center located in Kelisi. After two years of construction, the R & D team of the center has 15 Taiwan introduced talents (4 doctors and 11 graduate students) and more than 100 mainland R & D talents, which has become a classic case of cross-strait talent cooperation

is such an excellent product very expensive? Huang Tuozhong said with a smile that at present, the company only makes B2B (between enterprises) OEM products, and does not participate in the brand pricing of fence type aluminum base lead alloy composite anode. However, consumers need not worry at all. Although at the beginning of listing, the price will certainly be slightly higher than that of ordinary glass film, with the continuous expansion of the market, the output of the production line will also increase, and the cost will naturally decrease. At that time, the product price will be more people-friendly

Huang Tuozhong is full of confidence in the application prospect of antibacterial glass. In fact, in addition to glass film, antibacterial glass has a wide range of uses and great prospects. It is reported that it is mainly used in medical care, automotive touch and 3C electronic touch products, and can also be developed and applied in food, military and other industries

"as an emerging market, the antibacterial glass market is estimated to have reached hundreds of millions of dollars." Huang Tuozhong told kelistv that it has invested 7million yuan to build a leading production line, and the first year's output value may exceed billion yuan. In the future, it may invest more product lines to develop in the medical, automotive and other fields with a broader market

global glass () Department

Copyright © 2011 JIN SHI